Intel Corporation (NASDAQ:INTC) shares fell -0.17% in last trading session and ended the day at $29.42. INTC Gross Margin is 62.60% and its has a return on assets of 12.00%. Intel Corporation (NASDAQ:INTC) quarterly performance is -7.54%.
Intel Corporation (NASDAQ:INTC) announced a cash dividend payment of $0.26 per share is scheduled to be paid on March 01, 2016. Shareholders who purchased INTC prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 8.33% increase over the prior quarter.
Proto Labs, Inc. (NYSE:PRLB) ended the last trading day at $63.66. Company weekly volatility is calculated as 3.99% and price to cash ratio as 20.59. Proto Labs, Inc. (NYSE:PRLB) showed a weekly performance of 11.12%.
Proto Labs, Inc. (NYSE:PRLB)‘s stock had its “buy” rating restated by research analysts at Canaccord Genuity in a report issued on Thursday, AnalystRatingsNetwork.comreports. They presently have a $75.00 price objective on the stock. Canaccord Genuity’s price objective suggests a potential upside of 39.30% from the stock’s current price.
On 18 February, Covenant Transportation Group, Inc. (NASDAQ:CVTI) shares moved down -2.45% and was closed at $21.88. CVTI EPS growth in last 5 year was 21.50%. Covenant Transportation Group, Inc. (NASDAQ:CVTI) year to date (YTD) performance is 15.83%.
Covenant Transportation Group, Inc. (NASDAQ:CVTI) announced the appointment of Joey B. Hogan as President of CTG. Mr. Hogan previously served as Senior Executive Vice President of CTG and President of CTG’s Covenant Transport subsidiary. David R. Parker continues to serve as Chairman of the Board and Chief Executive Officer of CTG.
Natural Resource Partners LP (NYSE:NRP) shares moved down -9.90% in last trading session and ended the day at $8.74. NRP Gross Margin is 76.10% and its has a return on assets of -23.60%. Natural Resource Partners LP (NYSE:NRP) quarterly performance is -44.91%.
On 16 February, Natural Resource Partners LP (NYSE:NRP) announced that it has signed a definitive agreement to sell a portion of its oil and gas mineral rights and has closed a transaction to sell certain of its aggregates mineral rights for combined proceeds of $47.5 million before transaction expenses.
Blueprint Medicines Corporation (NASDAQ:BPMC) caters to the Healthcare space. Its weekly performance is 21.43%. On the last day of trading company shares ended up at $17.00. Blueprint Medicines Corporation (NASDAQ:BPMC) distance from 50-day simple moving average (SMA50) is -8.97%.
Blueprint Medicines Corporation (NASDAQ:BPMC) announced that Jeff Albers, Blueprint Medicines’ Chief Executive Officer, will present a company overview at the RBC Capital Markets 2016 Global Healthcare Conference on Tuesday, February 23, 2016 at 3:35 p.m. ET.
Leave a Reply